Delayed-release Formulations
Delayed-Release Formulations is a type of modified-release dosage form designed to release the active pharmaceutical ingredient at a predetermined time after administration, distinguished by a deliberate lag phase that postpones drug release until reaching a specific site or condition in the gastrointestinal tract.
216
Publications
7.2K
Citations
944
Authors
356
Institutions
Publications per year
2017–2026
39
Variants
Delayed-release Dosage Forms
216
1–5 of 216
944
Instituto de Recursos Naturales y Agrobiología de Sevilla, Spain
5 publications · 150 citations
5
h-index
5
h-index
5
h-index
5
h-index
4
h-index
1–5 of 944
356
Takeda (United States)
Deerfield, United States
6 h-index
27 publications
1.1K citations
Institute of Biophysics
Krasnoyarsk, Russia
5 h-index
26 publications
870 citations
Instituto de Recursos Naturales y Agrobiología de Sevilla
Seville, Spain
4 h-index
14 publications
385 citations
Hebrew University of Jerusalem
Jerusalem, Israel
4 h-index
13 publications
495 citations

Tulane University
New Orleans, United States
3 h-index
18 publications
1.5K citations

Christian-Albrechts-Universität zu Kiel
Kiel, Germany
3 h-index
19 publications
1.9K citations

Kumamoto University
Kumamoto, Japan
3 h-index
11 publications
278 citations
Mayo Clinic
Rochester, United States
3 h-index
14 publications
467 citations
1–8 of 356
Repository · 19 publications · 370 citations
15
h-index
9 publications · 519 citations
9
h-index
9 publications · 498 citations
9
h-index
8 publications · 279 citations
8
h-index
5 publications · 136 citations
5
h-index
1–5